Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 106.63B | 102.50B | 106.85B | 149.00B | 88.74B | 45.75B |
Gross Profit | 39.70B | 41.93B | 48.04B | 88.81B | 41.87B | 9.53B |
EBITDA | 40.64B | 41.81B | 50.18B | 85.75B | 42.98B | 6.60B |
Net Income | 8.23B | 8.81B | 11.88B | 28.75B | 8.56B | -5.50B |
Balance Sheet | ||||||
Total Assets | 139.09B | 131.14B | 143.58B | 158.02B | 147.12B | 121.97B |
Cash, Cash Equivalents and Short-Term Investments | 23.80B | 23.45B | 38.87B | 45.45B | 33.28B | 18.62B |
Total Debt | 34.35B | 30.09B | 31.80B | 32.17B | 36.24B | 38.12B |
Total Liabilities | 97.12B | 88.76B | 95.08B | 104.03B | 108.10B | 88.08B |
Stockholders Equity | 41.92B | 42.34B | 48.49B | 53.99B | 39.01B | 33.87B |
Cash Flow | ||||||
Free Cash Flow | 7.86B | 7.93B | 14.13B | 26.38B | 20.78B | 1.91B |
Operating Cash Flow | 21.07B | 20.11B | 24.70B | 35.14B | 28.82B | 10.39B |
Investing Cash Flow | -5.15B | -3.53B | -12.41B | -15.86B | -16.21B | -12.09B |
Financing Cash Flow | -12.94B | -17.74B | -18.14B | -15.41B | -4.84B | 2.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $74.09B | 5.69 | 19.48% | 14.68% | -13.68% | -13.96% | |
78 Outperform | $139.67B | 10.94 | 10.96% | 5.75% | -10.73% | -36.76% | |
78 Outperform | $53.34B | 20.22 | 4.83% | 6.79% | -6.31% | -33.87% | |
74 Outperform | $208.90B | 14.06 | 7.40% | 3.97% | ― | ― | |
67 Neutral | $62.17B | 8.11 | 19.22% | 8.76% | 1.19% | -7.87% | |
65 Neutral | $88.41B | 145.47 | 0.95% | 5.65% | -7.40% | -90.89% | |
56 Neutral | C$4.17B | 1.07 | 16.25% | 5.21% | 10.31% | -56.29% |